| Total | Male | Female | ||||||
---|---|---|---|---|---|---|---|---|---|
 | CAD patients | Control subjects | P Value | CAD patients | Control subjects | P Value | CAD patients | Control subjects | P Value |
Number(n) | 384 | 433 | Â | 270 | 220 | Â | 114 | 213 | Â |
Age(years) | 59.65 ± 0.501 | 58.91 ± 0.470 | 0.284 | 58.13 ± 0.563 | 58.86 ± 0.618 | 0.427 | 58.25 ± 0.714 | 58.95 ± 0.589 | 0.335 |
BMI(kg/m2) | 26.03 ± 0.167 | 25.22 ± 0.151 | 0.000* | 26.34 ± 0.194 | 25.33 ± 0.212 | 0.010* | 26.29 ± 0.315 | 25.12 ± 0.232 | 0.000* |
Glu(mmol/L) | 6.58 ± 0.162 | 5.48 ± 0.111 | 0.000* | 6.22 ± 0.211 | 6.07 ± 0.196 | 0.000* | 6.18 ± 0.200 | 5.77 ± 0.146 | 0.000* |
BUN(mmol/L) | 5.65 ± 0.102 | 5.19 ± 0.091 | 0.001* | 5.71 ± 0.227 | 5.27 ± 0.121 | 0.087 | 5.16 ± 0.142 | 5.51 ± 0.145 | 0.129 |
TG(mmol/L) | 2.43 ± 0.084 | 1.99 ± 0.067 | 0.000* | 2.46 ± 0.105 | 2.02 ± 0.090 | 0.003* | 2.35 ± 0.134 | 1.96 ± 0.107 | 0.027* |
TC(mmol/L) | 4.55 ± 0.067 | 4.23 ± 0.064 | 0.001* | 4.53 ± 0.083 | 4.28 ± 0.090 | 0.004* | 4.59 ± 0.111 | 4.19 ± 0.088 | 0.009* |
LDL-C(mmol/L) | 2.73 ± 0.045 | 2.56 ± 0.038 | 0.009* | 2.75 ± 0.057 | 2.60 ± 0.061 | 0.030* | 2.59 ± 0.074 | 2.52 ± 0.047 | 0.008* |
HDL-C(mmol/L) | 1.14 ± 0.031 | 1.12 ± 0.025 | 0.636 | 1.16 ± 0.042 | 1.12 ± 0.051 | 0.577 | 1.11 ± 0.031 | 1.12 ± 0.028 | 0.726 |
VLDL (mmol/L) | 0.49 ± 0.017 | 0.40 ± 0.014 | 0.000* | 0.49 ± 0.022 | 0.40 ± 0.019 | 0.003* | 0.47 ± 0.028 | 0.39 ± 0.028 | 0.027* |
DM(%) | 143(66.6Â %) | 72(33.4Â %) | 0.000* | 163(74.1Â %) | 36(25.9Â %) | 0.000* | 40(52.6Â %) | 36(47.4Â %) | 0.000* |
EH(%) | 221(52.2Â %) | 201(47.8Â %) | 0.030* | 145(60.4Â %) | 95(39.6Â %) | 0.024* | 53(35.3Â %) | 47(64.7Â %) | 0.991 |
Hyperlipidemia(%) | 136(54.8Â %) | 112(45.2Â %) | 0.000* | 165(53.9Â %) | 141(46.1Â %) | 0.012* | 79(37.3Â %) | 133(62.7Â %) | 0.040* |
Smoking(%) | 287(59.8Â %) | 193(40.2Â %) | 0.000* | 170(57.2Â %) | 127(42.8Â %) | 0.000* | 120(61.9Â %) | 74(38.1Â %) | 0.000* |